Bausch + Lomb <BLCO.N>: Leerink Partners initiates coverage with outperform rating; price target $24
BLCO•Related News
Summit Therapeutics Inc. <SMMT.O>: Jefferies raises to Buy from Hold; raises target price to $25 from $15
SMMT•
Novocure director Timothy Scannell retires from board
NVCR•
RBC To Mobilize $1.4 Billion To Back Canada's Next Global Technology Champions And Advance Nation-Building Efforts
RY•
Actuate reports preclinical synergy of elraglusib with RAS inhibitors in pancreatic cancer models
ACTU•
Women's apparel retailer J.Jill beats Q2 profit on tariff refund
JILL•